MARX Biotech Co (ROCO:7731) Market Cap: NT$2,542.0 Mil (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
10 GF Score
Price NT$4.87
! 4 Warning Signs
View Full Analysis

What is MARX Biotech Co Market Cap?

MARX Biotech Co ROCO:7731 -3.18% 10 Market Cap is NT$2,542.0 Mil as of Jul. 18, 2026. GuruFocus rates ROCO:7731 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 697 Healthcare Providers & Services companies, MARX Biotech Co ranks worse than 53.23% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MARX Biotech Co's share price for the quarter that ended in Dec. 2025 was NT$4.77. MARX Biotech Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 522.0 Mil. Therefore, MARX Biotech Co's market cap for the quarter that ended in Dec. 2025 was NT$2,489.8 Mil.

MARX Biotech Co's quarterly market cap declined from Dec. 2024 (NT$3,516.6 Mil) to Jun. 2025 (NT$2,600.7 Mil) and declined from Jun. 2025 (NT$2,600.7 Mil) to Dec. 2025 (NT$2,489.8 Mil).

MARX Biotech Co's annual market cap increased from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$3,516.6 Mil) but then declined from Dec. 2024 (NT$3,516.6 Mil) to Dec. 2025 (NT$2,489.8 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MARX Biotech Co's Enterprise Value for Today is NT$2,815.0 Mil.


MARX Biotech Co  (ROCO:7731) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


MARX Biotech Co Market Cap Related Terms


MARX Biotech Co Market Cap Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Market Cap Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial 0.00 0.00 0.00 3,516.57 2,489.85

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 4,756.44 3,516.57 2,600.74 2,489.85

MARX Biotech Co Market Cap Competitor Comparison

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MARX Biotech Co Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's Market Cap distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's Market Cap falls into.


ROCO:7731
10GF Score
MARX Biotech Co Ltd ROCO:7731
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

MARX Biotech Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=NT$4.77*521.981
=NT$2,489.8

MARX Biotech Co's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=NT$4.77*521.981
=NT$2,489.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of NT$2,542.0 Mil mean?
MARX Biotech Co (ROCO:7731) has a Market Cap of NT$2,542.0 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MARX Biotech Co and its competitors. According to the industry distribution chart, MARX Biotech Co ranks #371 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 53.2%.
Is MARX Biotech Co's Market Cap too high?
MARX Biotech Co's current Market Cap is NT$2,542.0 Mil. Based on the distribution chart, MARX Biotech Co ranks #371 out of 697 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MARX Biotech Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #371 out of 697 companies for Market Cap. This places MARX Biotech Co in the lower half of its industry. The industry median Market Cap is 100.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 100.90, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 100.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current Market Cap is NT$2,542.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Market Cap of NT$2,542.0 Mil. The current Market Cap is NT$2,542.0 Mil. MARX Biotech Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Market Cap is NT$2,542.0 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
10GF Score

Get the complete analysis for ROCO:7731

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.87
Price